1-6 of 6
David Vollmer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pharmacologic Activation of PKM2 Slows Lung Tumor Xenograft Growth

Free
K. Mark Parnell, Jason M. Foulks, Rebecca N. Nix, Adrianne Clifford, Jeremy Bullough, Bai Luo, Anna Senina, David Vollmer, Jihua Liu, Virgil McCarthy, Yong Xu, Michael Saunders, Xiao-Hui Liu, Scott Pearce, Kevin Wright, Marc O'Reilly, Michael V. McCullar, Koc-Kan Ho, Steven B. Kanner
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (8): 1453–1460.
https://doi.org/10.1158/1535-7163.MCT-13-0026
Published: 08 August 2013
View articletitled, Pharmacologic Activation of PKM2 Slows Lung Tumor Xenograft Growth
Open the PDF for Pharmacologic Activation of PKM2 Slows Lung Tumor Xenograft Growth in another window
Includes: Supplementary data
Journal Articles

Abstract B143: PKM2 metabolic activator slows lung cancer xenograft growth.

Free
K. Mark Parnell, Jason M. Foulks, Adrianne Clifford, Jeremy Bullough, Bai Luo, David Vollmer, Jihua Liu, Virgil McCarthy, Matthew Shaffer, Anna Senina, Xiao-Hui Liu, Scott Pearce, Yong Xu, Michael Saunders, Kan Ho, Michael V. McCullar, Steven B. Kanner
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): B143.
https://doi.org/10.1158/1535-7163.TARG-11-B143
Published: 12 November 2011
View articletitled, Abstract B143: PKM2 metabolic activator slows lung cancer xenograft growth.
Journal Articles

Abstract C200: Second-generation PIM inhibitors exhibit improved activity in solid tumor models in vitro.

Free
Jason M. Foulks, Yong Xu, Michael Saunders, Xiao-hui Liu, Benjamin Brenning, Adrianne Clifford, Marcus Wilkes, Bai Luo, Shuping Lai, Shannon Merx, Ashley Chan, Liwen Huang, David Vollmer, Anna Senina, Jihua Liu, Kan Ho, Michael V. McCullar, Steven B. Kanner
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): C200.
https://doi.org/10.1158/1535-7163.TARG-11-C200
Published: 12 November 2011
View articletitled, Abstract C200: Second-generation PIM inhibitors exhibit improved activity in solid tumor models in vitro.
Journal Articles

S110, a 5-Aza-2′-Deoxycytidine–Containing Dinucleotide, Is an Effective DNA Methylation Inhibitor In vivo and Can Reduce Tumor Growth

Free
Jody C. Chuang, Steven L. Warner, David Vollmer, Hariprasad Vankayalapati, Sanjeev Redkar, David J. Bearss, Xiangning Qiu, Christine B. Yoo, Peter A. Jones
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (5): 1443–1450.
https://doi.org/10.1158/1535-7163.MCT-09-1048
Published: 09 May 2010
View articletitled, S110, a 5-Aza-2′-Deoxycytidine–Containing Dinucleotide, Is an Effective DNA Methylation Inhibitor In vivo and Can Reduce Tumor Growth
Open the PDF for S110, a 5-Aza-2′-Deoxycytidine–Containing Dinucleotide, Is an Effective DNA Methylation Inhibitor In vivo and Can Reduce Tumor Growth in another window
Journal Articles

Abstract A190: In vivo activity of SGI‐110, a novel hypomethylating agent for treatment in hematology and solid malignancies

Free
Jason Scholl, David Vollmer, Jared Bearss, Carissa Jones, Virgil McCarthy, Paul Severson, Sanjeev Redkar, Rajashree Joshi‐Hangal, Roger Inloes, Chongtie Shi, David Bearss
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A190.
https://doi.org/10.1158/1535-7163.TARG-09-A190
Published: 10 December 2009
View articletitled, Abstract A190: In vivo activity of SGI‐110, a novel hypomethylating agent for treatment in hematology and solid malignancies
Journal Articles

Abstract C199: Development of potent, small‐molecule inhibitors of ETK

Free
David Vollmer, Jared Bearss, Carissa Jones, Virgil McCarthy, Chongtie Shi, Chunlin Tang, Eric Gourley, Xiao‐Hui Liu, William Hewitt, Hariprasad Vankayalapati, Steven Warner, Colin Olsen, David Bearss
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C199.
https://doi.org/10.1158/1535-7163.TARG-09-C199
Published: 10 December 2009
View articletitled, Abstract C199: Development of potent, small‐molecule inhibitors of ETK